Faced with many regulatory bottlenecks, the European cell therapy community must unite and confront these challenges head-on. The 3rd Cell Therapy Analytical Development Summit Europe is your unmissable opportunity to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA.

Join analytical development and quality control experts from industry-leaders like Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson and Johnson, GSK, MHRA, to tackle challenges from product characterisation to method validation and release preparation.

Time: 9:00 AM – 4:00 PM

Venue details: 15Hatfields, Chadwick Court, London, England, SE1 8DJ, United Kingdom

Prices: GBP 1799.00 – GBP 4297.00

Speakers: Alison Caldwell, Group Lead, Analytical Development, Resolution Therapeutics, Amanda Versteilen, Associate Director Analytical QC, Bristol Myers Squibb, and more